Skip to content

Genetic causes of cardiac arrest in patients with first heart attack

GEnetic causes of Ventricular Arrhythmias in patients with first STEMI (GEVAMI) study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN17749344
Enrollment
3000
Registered
2016-12-02
Start date
2011-07-03
Completion date
Unknown
Last updated
2017-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ventricular fibrillation Circulatory System Ventricular fibrillation

Interventions

Participants are recruited at the point of first STEMI. Baseline demographics and previous medical history are collected by researchers by using standardized questionnaires while the participant is in

Sponsors

University Hospital of Copenhagen
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Cases 1. First STEMI patients who experienced VF within the first 12 hours of symptoms of STEMI before PPCI 2. Age between 18 and 80 years 3. Caucasians 4. Cardiac symptoms lasting =12 hours 5. Acute ST-segment elevation revealed by ECG Controls: 1. First STEMI patients who did not have VF during the first 12 hours of symptoms of STEMI before PPCI 2. Age between 18 and 80 years 3. Caucasians 4. Cardiac symptoms lasting =12 hours 5. Acute ST-segment elevation revealed by ECG

Exclusion criteria

Exclusion criteria: 1. Cases and controls who developed VF during PPCI will be excluded because VF during PPCI is believed to be reperfusion induced; however, case patients with VF before PPCI who continued to have VF during PPCI can participate 2. Other exclusions included VF after PPCI 3. Congenital heart defects 4. Known structural heart disease 5. Use of class I and III antiarrhythmic drugs 6. Recent cancer 7. Major surgery or trauma within 4 weeks 8. Presentation with potassium concentration of 5 mmol/L 9. Because we also planned to identify genetic markers associated with VF, and because >90% of the Danish populations are white Danes, we excluded non-white Danes to reduce the risk of population stratification for future genetic analysis

Design outcomes

Primary

MeasureTime frame
Common and rare genetic variants associated with ventricular fibrillation (VF) during first ST-elevation myocardial infarction (STEMI), analysed by genome-wide association studies and next generation sequencing

Secondary

MeasureTime frame
All-cause mortality is measured using the Danish registries continuously for 5 years

Countries

Denmark

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026